Azitrobac

Azitrobac may be available in the countries listed below.

Ingredient matches for Azitrobac

Azithromycin

Azithromycin is reported as an ingredient of Azitrobac in the following countries:

• Ecuador

International Drug Name Search

Flutamid-ratiopharm

Flutamid-ratiopharm may be available in the countries listed below.

Ingredient matches for Flutamid-ratiopharm

Flutamide

Flutamide is reported as an ingredient of Flutamid-ratiopharm in the following countries:

• Germany

International Drug Name Search

Alprazolam Intensol

In the US, Alprazolam Intensol (alprazolam systemic) is a member of the drug class benzodiazepines and is used to treat Anxiety, Depression, Dysautonomia, Panic Disorder and Tinnitus.

US matches:

• Alprazolam Intensol Solution


• Alprazolam Intensol

Ingredient matches for Alprazolam Intensol

Alprazolam

Alprazolam is reported as an ingredient of Alprazolam Intensol in the following countries:

• United States

International Drug Name Search

Sekodin

Sekodin may be available in the countries listed below.

Ingredient matches for Sekodin

Oxolamine

Oxolamine citrate (a derivative of Oxolamine) is reported as an ingredient of Sekodin in the following countries:

• Turkey

International Drug Name Search

Atropina Solfato Galenica

Atropina Solfato Galenica may be available in the countries listed below.

Ingredient matches for Atropina Solfato Galenica

Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Atropina Solfato Galenica in the following countries:

• Italy

International Drug Name Search

SP54

SP54 may be available in the countries listed below.

Ingredient matches for SP54

Pentosan Polysulfate

Pentosan Polysulfate sodium (a derivative of Pentosan Polysulfate) is reported as an ingredient of SP54 in the following countries:

• Hungary

International Drug Name Search

IbuTAD

IbuTAD may be available in the countries listed below.

Ingredient matches for IbuTAD

Ibuprofen

Ibuprofen is reported as an ingredient of IbuTAD in the following countries:

• Germany

International Drug Name Search

Tocalm

Tocalm may be available in the countries listed below.

Ingredient matches for Tocalm

Ambroxol

Ambroxol is reported as an ingredient of Tocalm in the following countries:

• Chile

International Drug Name Search

Azitromycine Merck

Azitromycine Merck may be available in the countries listed below.

Ingredient matches for Azitromycine Merck

Azithromycin

Azithromycin is reported as an ingredient of Azitromycine Merck in the following countries:

• Netherlands

International Drug Name Search

Alisrythm

Alisrythm may be available in the countries listed below.

Ingredient matches for Alisrythm

Pilsicainide

Pilsicainide hydrochloride (a derivative of Pilsicainide) is reported as an ingredient of Alisrythm in the following countries:

• Japan

International Drug Name Search

Ferromyn S

Ferromyn S may be available in the countries listed below.

Ingredient matches for Ferromyn S

Ferrous Sulfate

Ferrous Sulfate is reported as an ingredient of Ferromyn S in the following countries:

• Iceland

International Drug Name Search

Morphin Heumann

Morphin Heumann may be available in the countries listed below.

Ingredient matches for Morphin Heumann

Morphine

Morphine sulphate pentahydrate (a derivative of Morphine) is reported as an ingredient of Morphin Heumann in the following countries:

• Germany

International Drug Name Search

Dimetapp Cold and Cough Liquigel

Generic Name: brompheniramine/dextromethorphan/phenylpropanolamine (brome fen IR a meen/dex troe meth OR fan/fen ill proe pa NOLE a meen)

Brand Names: Delhistine DM, Dimetapp Cold and Cough Liquigel, Dimetapp DM, DM Cold and Cough, Histinex DM, Iohist DM, Liquihistine DM, Poly DM, Poly Histine DM, Prohistine DM, Trihist DM

What is Dimetapp Cold and Cough Liquigel (brompheniramine/dextromethorphan/phenylpropanolamine)?

Brompheniramine is an antihistamine. It blocks the effects of the naturally occurring chemical histamine in your body. Brompheniramine prevents sneezing; itchy, watery eyes and nose; and other symptoms of allergies and hay fever.

Dextromethorphan is a cough suppressant. It suppresses an area in the brain that causes coughing

Phenylpropanolamine is a decongestant. It constricts (shrinks) blood vessels (veins and arteries). This reduces the blood flow, allowing nasal passages to open up.

Brompheniramine/dextromethorphan/phenylpropanolamine is used to treat nasal congestion, sinusitis (inflammation of the sinuses), and coughs associated with allergies, hay fever, and the common cold.

Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.

Brompheniramine/dextromethorphan/phenylpropanolamine may also be used for purposes other than those listed in this medication guide.

What is the most important information I should know about Dimetapp Cold and Cough Liquigel (brompheniramine/dextromethorphan/phenylpropanolamine)?

Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.

Use caution when driving, operating machinery, or performing other hazardous activities. Brompheniramine/dextromethorphan/phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking brompheniramine/dextromethorphan/phenylpropanolamine.

Do not take more of this medication than is recommended. If your symptoms do not improve, or if they worsen, talk to your doctor.

Who should not take Dimetapp Cold and Cough Liquigel (brompheniramine/dextromethorphan/phenylpropanolamine)?

Do not take brompheniramine/dextromethorphan/phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Before taking this medication, tell your doctor if you have

• kidney disease,


• liver disease,


• 
  

  diabetes,

  
  


• 
  

  glaucoma,

  
  


• 
  

  any type of heart disease or high blood pressure,

  
  


• 
  

  thyroid disease,

  
  


• 
  

  emphysema or chronic bronchitis, or

  
  


• 
  

  difficulty urinating or have an enlarged prostate.

  
  

You may not be able to take brompheniramine/dextromethorphan/phenylpropanolamine, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.

It is not known whether brompheniramine/dextromethorphan/phenylpropanolamine will harm an unborn baby. Do not take this medication without first talking to your doctor if you are pregnant. Brompheniramine/dextromethorphan/phenylpropanolamine passes into breast milk. Do not take this medication without first talking to your doctor if you are breast-feeding a baby. If you are over 65 years of age, you may be more likely to experience side effects from brompheniramine/dextromethorphan/phenylpropanolamine. You may require a lower dose of this medication. Read the package label for directions or consult your doctor or pharmacist before treating a child with this medication. Children are more susceptible than adults to the effects of medicines and may have unusual reactions.

How should I take Dimetapp Cold and Cough Liquigel (brompheniramine/dextromethorphan/phenylpropanolamine)?

Take brompheniramine/dextromethorphan/phenylpropanolamine exactly as directed. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.

Take each dose with a full glass of water.

To ensure that you get a correct dose, measure the liquid forms of brompheniramine/dextromethorphan/phenylpropanolamine with a special dose-measuring spoon or cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.

Do not take more of this medication than is recommended. An overdose of this medication can cause serious harm.

Do not take brompheniramine/dextromethorphan/phenylpropanolamine for longer than 7 days in a row. If your symptoms do not improve, if they get worse, or if you have a fever, talk to your doctor.

Store brompheniramine/dextromethorphan/phenylpropanolamine at room temperature away from moisture and heat.

What happens if I miss a dose?

Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication.

What happens if I overdose?

Seek emergency medical attention.

Symptoms of a brompheniramine/dextromethorphan/phenylpropanolamine overdose include dry mouth, large pupils, flushing, nausea, vomiting, hyperactivity, or hallucinations.

What should I avoid while taking Dimetapp Cold and Cough Liquigel (brompheniramine/dextromethorphan/phenylpropanolamine)?

Use caution when driving, operating machinery, or performing other hazardous activities. Brompheniramine/dextromethorphan/phenylpropanolamine may cause dizziness. If you experience dizziness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while taking brompheniramine/dextromethorphan/phenylpropanolamine.

Brompheniramine/dextromethorphan/phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine/dextromethorphan/phenylpropanolamine is taken with any of these medications.

Dimetapp Cold and Cough Liquigel (brompheniramine/dextromethorphan/phenylpropanolamine) side effects

Serious side effects are unlikely to occur. Stop taking brompheniramine/dextromethorphan/phenylpropanolamine and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).

Other, less serious side effects may be more likely to occur. Continue to take brompheniramine/dextromethorphan/phenylpropanolamine and talk to your doctor or try another similar medication if you experience

• 
  

  dryness of the eyes, nose, and mouth;

  
  


• 
  

  drowsiness or dizziness;

  
  


• 
  

  blurred vision;

  
  


• 
  

  difficulty urinating; or

  
  


• 
  

  excitation in children.

  
  

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.

What other drugs will affect Dimetapp Cold and Cough Liquigel (brompheniramine/dextromethorphan/phenylpropanolamine)?

Do not take brompheniramine/dextromethorphan/phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Do not take other over-the-counter cough, cold, allergy, diet, or sleep aids while taking brompheniramine/dextromethorphan/phenylpropanolamine without first talking to your doctor or pharmacist. Other medications may also contain brompheniramine, dextromethorphan, phenylpropanolamine, or other similar drugs. You may accidentally take too much of these medicines.

Brompheniramine/dextromethorphan/phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine/dextromethorphan/phenylpropanolamine is taken with any of these medications.

Drugs other than those listed here may also interact with brompheniramine/dextromethorphan/phenylpropanolamine. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.

More Dimetapp Cold and Cough Liquigel resources

• Dimetapp Cold and Cough Liquigel Drug Interactions
• Dimetapp Cold and Cough Liquigel Support Group
• 0 Reviews for Dimetapp Cold and Cough Liquigel - Add your own review/rating

Compare Dimetapp Cold and Cough Liquigel with other medications

• Cold Symptoms

Where can I get more information?

• Your pharmacist has additional information about brompheniramine/ dextromethorphan/phenylpropanolamine written for health professionals that you may read.

What does my medication look like?

Brompheniramine/dextromethorphan/phenylpropanolamine is available over the counter and with a prescription in many different formulations. Ask your pharmacist any questions you have about this medication, especially if it is new to you.

Lovastatina Combino Pharm

Lovastatina Combino Pharm may be available in the countries listed below.

Ingredient matches for Lovastatina Combino Pharm

Lovastatin

Lovastatin is reported as an ingredient of Lovastatina Combino Pharm in the following countries:

• Spain

International Drug Name Search

Sulfadimethoxine

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01ED01

CAS registry number (Chemical Abstracts Service)

0000122-11-2

Chemical Formula

C12-H14-N4-O4-S

Molecular Weight

310

Therapeutic Category

Antibacterial: Sulfonamid

Chemical Name

Benzenesulfonamide, 4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)-

Foreign Names

• Sulfadimethoxinum (Latin)
• Sulfadimethoxin (German)
• Sulfadiméthoxine (French)
• Sulfadimetoxina (Spanish)

Generic Names

• Sulfadimethoxine (OS: BAN, JAN)
• Sulfadiméthoxine (OS: DCF)
• Sulfadimetoxina (OS: DCIT)
• Solfadimetossina (IS)
• Sulphadimethoxine (IS)
• Sulfadimethoxine (PH: USP 32)
• Sulfadiméthoxine pour usage vétérinaire (PH: Ph. Franç. Xe édit)
• Sulfadimetoxina (PH: F.U. XII)
• Sulphadimethoxine (PH: BP 1988)
• Sulfadimethoxine Sodium (PH: USP 32)

Brand Names

• Abcid
  Daiichi Sankyo, Japan; Nipro GenephaNipurojenefa, Japan



• Acti Méthoxine (veterinary use)
  Laboratoires Biové, France



• Agribon (veterinary use)
  Pfizer Animal Health, United States



• Albon (veterinary use)
  Pfizer Animal Health, United States



• Amidurene (veterinary use)
  Laboratoires Biové, France



• Ampidiar (Sulfadimethoxine and Ampicillin (veterinary use))
  Novartis Santé Animale, France



• Ascodimetossina (veterinary use)
  Ascor, Italy



• Bactrovet (veterinary use)
  Schering-Plough Animal Health, United States



• Chemitrim (Sulfadimethoxine and Trimethoprim (veterinary use))
  Chemifarma, Italy



• Cofamix Sulfadiméthoxine (veterinary use)
  Coophavet, France



• Cunicoxil (veterinary use)
  Laboratoires Biové, France



• Di Methox (veterinary use)
  Agri Laboratories, United States



• Dimetoprim (Sulfadimethoxine and Trimethoprim (veterinary use))
  AFI, Italy



• Dimetossin (veterinary use)
  Chemifarma, Italy



• Dimetox (veterinary use)
  Tre I, Italy



• Dimexin
  Fuso Pharmaceutical, Japan



• Emericid (veterinary use)
  Virbac, France



• Kokzidiol SD (veterinary use)
  Albrecht, Germany; Serumber, Germany; WDT, Germany; Weinboeh, Germany



• Medacide SDM (veterinary use)
  Boehringer Ingelheim Vetmedica, United States



• Metoxyl (veterinary use)
  Virbac, France



• Océcoxil (Sulfadimethoxine and Pyrimethamine (veterinary use))
  Virbac, France



• Oxécoxil (Sulfadimethoxine and Pyrimethamine (veterinary use))
  Virbac, France



• Prazil (Sulfadimethoxine and Trimethoprim (veterinary use))
  Merial, Italy



• Prémélange CS (Sulfadimethoxine and Colistin (veterinary use))
  Laboratoires Franvet, France



• Prémélange TS (Sulfadimethoxine and Oxytetracycline (veterinary use))
  Laboratoires Franvet, France



• Prémélange Z29 (Sulfadimethoxine and Oxytetracycline (veterinary use))
  Laboratoires Franvet, France



• Primor (Sulfadimethoxine and Ormetoprim (veterinary use))
  Pfizer Animal Health, United States



• Relardon (veterinary use)
  Vetoquinol, Switzerland



• Retardon (veterinary use)
  Chassot, Germany



• Rofenaid (Sulfadimethoxine and Ormetoprim (veterinary use))
  Alpharma Animal Health, United States



• Romet (Sulfadimethoxine and Ormetoprim (veterinary use))
  Pharmaq, United States



• Suldimet (veterinary use)
  Doxal, Italy



• Sulfadimethoxine
  BHFZ, Georgia



• Sulfadimethoxine (veterinary use)
  Agri Laboratories, United States; IVX, United States



• Sulfadiméthoxine (veterinary use)
  Laboratoires Franvet, France



• Sulfadimetossina
  Nova Argentia, Italy



• Sulfadimetossina (veterinary use)
  Chemifarma, Italy; Filozoo, Italy; Sintofarm, Italy; Vetem, Italy



• Sulfalon (veterinary use)
  Virbac, France



• Sulfamed G (veterinary use)
  Cross Vetpharm, United States



• Sulfaprime (Sulfadimethoxine and Oxytetracycline, + Trimethoprim (veterinary use))
  Zoopan - Produtos Pecuários, Lda, Portugal



• Sulfasol (veterinary use)
  Med Pharmex, United States



• Sulforal (veterinary use)
  Med Pharmex, United States



• Tiforine (Sulfadimethoxine and Trimethoprim (veterinary use))
  Companhia Portuguesa de Higiene Pharma, Portugal



• Trimethosel-P (Sulfadimethoxine and Trimethoprim (veterinary use))
  Selecta, Germany



• Trimetoprim-Sulfadimetossina (Sulfadimethoxine and Trimethoprim (veterinary use))
  Chemifarma, Italy



• Ultrasulfon (veterinary use)
  Streuli Vet, Switzerland



• Bactotril (Sulfadimethoxine and Trimethoprim (veterinary use))
  Virbac, France



• Biaprim (Sulfadimethoxine and Trimethoprim (veterinary use))
  Laboratoires Biové, France



• Coccidex (veterinary use)
  Casa dos Cereais, Portugal; Laboratoire Ornis, France



• Coccilyse (veterinary use)
  Laboratoires Moureau, France



• Cofamix TMP (Sulfadimethoxine and Trimethoprim (veterinary use))
  Coophavet, France



• Concentrat (Sulfadimethoxine and Trimethoprim (veterinary use))
  Sogeval, France



• Corylap (Sulfadimethoxine and Trimethoprim (veterinary use))
  Laboratoires Biové, France



• Coxi Plus (veterinary use)
  Versele-Laga, Portugal; Vetrepharm, United Kingdom



• Disulfox (veterinary use)
  Intervet, South Africa



• Ecosulf (veterinary use)
  Afrivet, South Africa



• Maxisulf (veterinary use)
  Cipla Agrimed, South Africa



• Prequinix (Sulfadimethoxine and Trimethoprim (veterinary use))
  Virbac, France



• Pridimet (Sulfadimethoxine and Trimethoprim (veterinary use))
  Fatro, Italy



• Sadimet (veterinary use)
  Fatro, Italy



• Sulfadimethoxine (veterinary use)
  Alfasan, Netherlands



• Sulfadimetossina+Trimetoprim (Sulfadimethoxine and Trimethoprim (veterinary use))
  Ascor, Italy



• Sulfadimetossina (veterinary use)
  Ascor, Italy; Doxal, Italy; Sintofarm, Italy



• Sunix (veterinary use)
  Coophavet, France



• Trimédoxyne (Sulfadimethoxine and Trimethoprim (veterinary use))
  Coophavet, France



• Trimethoprim-Sulfadimetossina (Sulfadimethoxine and Trimethoprim (veterinary use))
  Filozoo, Italy



• Triméthosulfa (Sulfadimethoxine and Trimethoprim (veterinary use))
  Coophavet, France



• Trimethox (Sulfadimethoxine and Trimethoprim (veterinary use))
  Sogeval, France



• Trisulmix (Sulfadimethoxine and Trimethoprim (veterinary use))
  Coophavet, France



• Vetitrim (Sulfadimethoxine and Trimethoprim (veterinary use))
  Eurovet, Belgium

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Praxavet TMPS

Praxavet TMPS may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Praxavet TMPS

Sulfadiazine

Sulfadiazine is reported as an ingredient of Praxavet TMPS in the following countries:

• Netherlands

Trimethoprim

Trimethoprim is reported as an ingredient of Praxavet TMPS in the following countries:

• Netherlands

International Drug Name Search

Chemivita Vitamin A Cream

Chemivita Vitamin A Cream may be available in the countries listed below.

Ingredient matches for Chemivita Vitamin A Cream

Retinol

Retinol palmitate (a derivative of Retinol) is reported as an ingredient of Chemivita Vitamin A Cream in the following countries:

• New Zealand

International Drug Name Search

Bio Crem A-Bioplix-Biox

Bio Crem A-Bioplix-Biox may be available in the countries listed below.

Ingredient matches for Bio Crem A-Bioplix-Biox

Retinol

Retinol is reported as an ingredient of Bio Crem A-Bioplix-Biox in the following countries:

• Peru

International Drug Name Search

Ulis

Ulis may be available in the countries listed below.

Ingredient matches for Ulis

Cimetidine

Cimetidine is reported as an ingredient of Ulis in the following countries:

• Italy

International Drug Name Search

Itraviron

Itraviron may be available in the countries listed below.

Ingredient matches for Itraviron

Itraconazole

Itraconazole is reported as an ingredient of Itraviron in the following countries:

• Greece

International Drug Name Search

Ipratropium Bromide

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R01AX03,R03BB01

CAS registry number (Chemical Abstracts Service)

0022254-24-6

Chemical Formula

C20-H30-Br-N-O3

Molecular Weight

412

Therapeutic Categories

Parasympatholytic agent

Bronchodilator

Chemical Name

8-Azoniabicyclo[3.2.1]octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, bromide, (endo,syn)-(±)-

Foreign Names

• Ipratropii Bromidum (Latin)
• Ipratropium bromid (German)
• Bromure d'Ipratropium (French)
• Bromuro de ipratropio (Spanish)

Generic Names

• Ipratropio bromuro (OS: DCIT)
• Ipratropium (bromure d') (OS: DCF)
• Ipratropium Bromide (OS: BAN, JAN)
• Sch 1000 (IS)
• Ipratropium Bromide (OS: USAN)
• Sch 1000-Br-monohydrate (IS)
• Ipratropii bromidum (PH: Ph. Eur. 6)
• Ipratropium (bromure d') (PH: Ph. Eur. 6)
• Ipratropium Bromide (PH: BP 2010, JP XIV, Ph. Eur. 6, USP 32)
• Ipratropiumbromid (PH: Ph. Eur. 6)

Brand Names

• Adco-Combineb (Ipratropium Bromide and Salbutamol)
  Adcock Ingram Critical Care, South Africa



• Adco-Ipratropium
  Adcock Ingram Critical Care, South Africa



• Adco-Nebrafen (Ipratropium Bromide and Fenoterol)
  Adcock Ingram Critical Care, South Africa



• Aeron
  Sigma, Australia



• Aerotrop
  Pablo Cassara, Argentina



• Aerovent
  Teva, Israel



• Albuterol Sulfate and Ipratropium Bromide (Ipratropium Bromide and Salbutamol sulfate)
  Apotex, United States; Breath Asure, United States; Cobalt, United States; Nephron, United States; Sandoz, United States; Teva USA, United States; Watson, United States



• Almeida (Ipratropium Bromide and Salbutamol)
  Savio, Italy



• Alovent
  Boehringer Ingelheim, Venezuela



• Alvent
  Farmalab, Brazil



• Apo-Ipravent
  Apotex, Canada; Apotex, Guyana; Apotex, New Zealand



• Apoven
  Curex, Israel; Genepharm, Australia



• Apovent
  Curex, Israel



• Aspromio
  Chalver, Colombia



• Atem
  Chiesi, Egypt; Chiesi, Jordan; Chiesi, Kuwait; Chiesi, Lebanon; Chiesi, Sri Lanka; Chiesi, Saudi Arabia; Chiesi, Syria



• Atronase
  Boehringer Ingelheim, Belgium; Boehringer Ingelheim International, Luxembourg



• Atropair Steri-Nebs
  Teva Pharma, Switzerland



• Atrovent Beta (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, South Africa



• Atrovent Inhaletas
  Boehringer Ingelheim, Spain



• Atrovent Monodosis
  Boehringer Ingelheim, Spain



• Atrovent Nasal Spray 0.03%
  Boehringer Ingelheim, Chile; Boehringer Ingelheim, Czech Republic



• Atrovent Nasal
  Boehringer Ingelheim, Spain; Boehringer Ingelheim, New Zealand



• Atrovent
  Boehringer Ingelheim, United Arab Emirates; Boehringer Ingelheim, Argentina; Boehringer Ingelheim, Bahrain; Boehringer Ingelheim, Brazil; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Chile; Boehringer Ingelheim, China; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Costa Rica; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Dominican Republic; Boehringer Ingelheim, Algeria; Boehringer Ingelheim, Estonia; Boehringer Ingelheim, Egypt; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Greece; Boehringer Ingelheim, Guatemala; Boehringer Ingelheim, Guyana; Boehringer Ingelheim, Hong Kong; Boehringer Ingelheim, Honduras; Boehringer Ingelheim, Croatia (Hrvatska); Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Indonesia; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Israel; Boehringer Ingelheim, Iraq; Boehringer Ingelheim, Iceland; Boehringer Ingelheim, Jordan; Boehringer Ingelheim, Kuwait; Boehringer Ingelheim, Lebanon; Boehringer Ingelheim, Luxembourg; Boehringer Ingelheim, Libya; Boehringer Ingelheim, Malta; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Malaysia; Boehringer Ingelheim, Nicaragua; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Norway; Boehringer Ingelheim, Oman; Boehringer Ingelheim, Panama; Boehringer Ingelheim, Peru; Boehringer Ingelheim, Qatar; Boehringer Ingelheim, Saudi Arabia; Boehringer Ingelheim, Singapore; Boehringer Ingelheim, El Salvador; Boehringer Ingelheim, Thailand; Boehringer Ingelheim, Tunisia; Boehringer Ingelheim, Taiwan; Boehringer Ingelheim, United States; Boehringer Ingelheim, Yemen; Boehringer Ingelheim, South Africa; Euro, Netherlands



• Atrovent (veterinary use)
  Boehringer Ingelheim Vetmedica, United Kingdom



• Atrovent Comp (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, Finland



• Berodual (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, Austria; Boehringer Ingelheim, Switzerland; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Indonesia; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Singapore; Boehringer Ingelheim, Slovenia; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim, Vietnam



• Berodualin (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, Austria



• Biwind (Ipratropium Bromide and Salbutamol)
  Valeas, Italy



• Breva (Ipratropium Bromide and Salbutamol)
  Valeas, Italy



• Bromuro de ipratopio MK
  MK, Colombia



• Bromuro de Ipratropio Aldo Union
  Aldo Union, Spain



• Bromuro de Ipratropio
  GP Pharm, Peru



• Bronchodual (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, Denmark; Boehringer Ingelheim, Tunisia



• Ciplatropiun
  Biotoscana, Colombia



• Combivent (Ipratropium Bromide and Salbutamol)
  Boehringer Ingelheim, Canada; Boehringer Ingelheim, China; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Peru; Boehringer Ingelheim, Turkey



• Cyclovent
  Teva, Latvia



• Demoren (Ipratropium Bromide and Salbutamol)
  Demo, Greece



• Dospir (Ipratropium Bromide and Salbuamol)
  Boehringer Ingelheim, Switzerland



• Duoastalin (Ipratropium Bromide and Salbutamol)
  Biotoscana, Colombia



• Duolin (Ipratropium Bromide and Salbutamol)
  Cipla Medpro, South Africa



• DuoNeb (Ipratropium Bromide and Salbutamol)
  Dey, United States



• Duovent Orifarm (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, Denmark



• Duovent Paranova (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, Denmark



• Duovent (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, Canada; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Luxembourg; Boehringer Ingelheim, Singapore



• Flavuril
  AC Farma, Peru



• Gen-Combo Sterinebs (Ipratropium Bromide and Salbutamol)
  Genpharm, Canada



• Gen-Ipratropium
  Genpharm, Canada



• GenRX Ipratropium
  Apotex, Australia



• I-Patrimul Compuesto (Ipratropium Bromide and Salbutamol)
  Roemmers, Peru



• I-Patrimul
  Roemmers, Peru



• Iprabon
  Zambon, Brazil



• Ipracip
  Cipla, Sri Lanka



• Ipramol Steri-Neb (Ipratropium Bromide and Salbutamol)
  Teva, Denmark



• Ipramol (Ipratropium Bromide and Salbutamol)
  Ivax, Netherlands; Teva, Ireland



• Ipramol Steri-Nebs (Ipratropium Bromide and Salbutamol)
  Teva Pharma, Switzerland



• Iprarex
  Biotoscana, Peru



• Iprasthma
  Excelsior, Taiwan



• Ipratropio Bromuro
  Bestpharma, Chile



• Ipratropium Aguettant
  Aguettant, Tunisia



• Ipratropium Bromide
  Actavis, United States; Bausch & Lomb, United States; Dey, United States; Holopack, United States; Landela Pharmaceutical, United States; Nephron, United States; Novex, United States; Pharmascience, United States; Respirare, United States; Roxane, United States; RxElite, United States; Warrick, United States



• Ipratropium Steri Neb
  Airflow, New Zealand; Teva Pharmaceuticals, United Kingdom



• Ipratropiumbromid Arrow
  Arrow, Netherlands; Arrow Generics Ltd.GB, Denmark



• Ipratropiumbromide
  Pharmachemie, Netherlands



• Ipravent
  Cipla, India; Cipla, Sri Lanka; Cipla, Romania; PfizerPerth, Australia



• Iprex
  Square, Bangladesh



• Ipvent
  Cipla Medpro, South Africa



• Naos (Ipratropium Bromide and Salbutamol)
  Mediolanum, Italy



• Otricomb (Ipratropium Bromide and Xylometazoline)
  Novartis, Sweden



• Otrivin (Ipratropium Bromide and Xylometazoline)
  Novartis, Greece; Novartis, Sweden



• Otrivine duo (Ipratropium Bromide and Xylometazoline)
  Novartis, Belgium



• ratio-Ipra Sal UDV (Ipratropium Bromide and Salbutamol)
  ratiopharm, Canada



• ratio-Ipratropium
  ratiopharm, Canada



• Respontin
  GlaxoSmithKline, United Kingdom



• Rhinovent
  Boehringer Ingelheim, Switzerland



• Rinatec
  Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Ireland



• Rinovagos
  Valeas, Italy



• Salpromio (Ipratropium Bromide and Salbutamol)
  Chalver, Colombia



• Steri-Neb Ipratropium
  Ivax, Ireland; Norton, Poland



• Zycomb (Ipratropium Bromide and Xylometazoline)
  Nycomed, Norway



• Zymelin Plus (Ipratropium Bromide and Xylometazoline)
  Nycomed, Denmark



• Aerotrop
  D & M Pharma, Chile



• Atem
  Promedica, Italy



• Atrodual (Ipratropium Bromide and Salbutamol)
  Boehringer Ingelheim, Finland



• Atrovent N
  Boehringer Ingelheim, Czech Republic; Boehringer Ingelheim, Georgia; Boehringer Ingelheim, Lithuania



• Atrovent
  Boehringer Ingelheim, Austria; Boehringer Ingelheim, Australia; Boehringer Ingelheim, Bosnia & Herzegowina; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Bulgaria; Boehringer Ingelheim, Brazil; Boehringer Ingelheim, Costa Rica; Boehringer Ingelheim, Czech Republic; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Dominican Republic; Boehringer Ingelheim, Spain; Boehringer Ingelheim, Finland; Boehringer Ingelheim, France; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Georgia; Boehringer Ingelheim, Greece; Boehringer Ingelheim, Guatemala; Boehringer Ingelheim, Honduras; Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Iceland; Boehringer Ingelheim, Japan; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Nicaragua; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, New Zealand; Boehringer Ingelheim, Panama; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Portugal; Boehringer Ingelheim, Romania; Boehringer Ingelheim, Russian Federation; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Slovakia; Boehringer Ingelheim, El Salvador; Boehringer Ingelheim, United States; Boehringer Ingelheim International, Luxembourg; Delphi, Netherlands; Euro, Netherlands; Teijin Pharma, Japan



• Atrovent Nasal
  Boehringer Ingelheim, Canada; Boehringer Ingelheim, Romania; Boehringer Ingelheim, Sweden



• Berodual Respimat (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, Germany



• Berovent (Ipratropium Bromide and Salbutamol)
  Boehringer Ingelheim, Greece



• Bronchodual (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, France



• Combivent (Ipratropium Bromide and Salbutamol)
  Boehringer Ingelheim, Austria; Boehringer Ingelheim, Australia; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Denmark; Boehringer Ingelheim, United Kingdom; Boehringer Ingelheim, Indonesia; Boehringer Ingelheim, Ireland; Boehringer Ingelheim, Luxembourg; Boehringer Ingelheim, Oman; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, Singapore; Boehringer Ingelheim, United States; Boehringer Ingelheim, Vietnam; Boehringer Ingelheim, South Africa



• Duovent HFA (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, South Africa



• Duovent (Ipratropium Bromide and Fenoterol)
  Boehringer Ingelheim, Belgium



• Ipramid
  Beximco, Bangladesh



• Ipramol Teva
  Teva, Germany



• Ipramol (Ipratropium Bromide and Salbutamol)
  Teva, Sweden



• Ipratrin
  Alphapharm, Australia



• Ipratropium Aguettant
  Aguettant, France



• Ipratropium Arrow
  Arrow, France



• Ipratropium Mylan
  Mylan, France



• Ipratropium Teva Adultes
  Teva Santé, France



• Ipratropium Teva Enfants (pediatric)
  Teva Santé, France



• Ipratropiumbromid Arrow
  Arrow, Sweden



• Ipraxa
  Ivax, Netherlands; Teva, Sweden



• Itrop
  Boehringer Ingelheim, Austria; Boehringer Ingelheim, Germany



• Otrifar (Ipratropium Bromide and Xylometazoline)
  Novartis, Portugal



• Sapimol (Ipratropium Bromide and Salbutamol)
  Arrow, Sweden

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Ofloxacin-B

Ofloxacin-B may be available in the countries listed below.

Ingredient matches for Ofloxacin-B

Ofloxacin

Ofloxacin is reported as an ingredient of Ofloxacin-B in the following countries:

• Hungary

International Drug Name Search

Cardiopirin

Cardiopirin may be available in the countries listed below.

Ingredient matches for Cardiopirin

Aspirin

Acetylsalicylic Acid is reported as an ingredient of Cardiopirin in the following countries:

• Croatia (Hrvatska)


• Israel


• Poland


• Serbia


• Slovenia

International Drug Name Search

Firmagon

Firmagon is a brand name of degarelix, approved by the FDA in the following formulation(s):

FIRMAGON (degarelix acetate - powder; subcutaneous)

• 
  Manufacturer: FERRING
  
  Approval date: December 24, 2008
  
  Strength(s): EQ 120MG BASE/VIAL ^[RLD], EQ 80MG BASE/VIAL
  

Has a generic version of Firmagon been approved?

No. There is currently no therapeutically equivalent version of Firmagon available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Firmagon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  GnRH antagonists
  Patent 5,925,730
  Issued: July 20, 1999
  Inventor(s): Semple; Graeme & Jiang; Guangcheng
  Assignee(s): Ferring BV
  Peptides are provided which have improved duration of GnRH antagonistic properties. These antagonists may be used to regulate fertility and to treat steroid-dependent tumors and for other short-term and long-term treatment indications. These antagonists have a derivative of aminoPhe or its equivalent in the 5- and/or 6-positions. This derivative contains a carbamoyl group or a heterocycle including a urea in its side chain. Particularly effective decapeptides, which continue to exhibit very substantial suppression of LH secretion at 96 hours following injection, have the formulae: Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph(hydroorotyl)-D-4Aph(acetyl)-Leu-Lys(isopr opyl)-Pro-D-Ala-NH.sub.2, and Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph(hydroorotyl)-D-4Amf(Q.sub.2)-Leu-Lys(isop ropyl)-Pro-D-Ala-NH.sub.2, wherein Q.sub.2 is Cbm or MeCbm.
  
  Patent expiration dates:
  
  
  • April 11, 2017
    
    ✓ 
    Patent use: GNRH ANTAGONIST INDICATED FOR TREATMENT OF PATIENTS WITH ADVANCED PROSTATE CANCER
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • December 24, 2013 - NEW CHEMICAL ENTITY
  
  

See also...

• Firmagon Consumer Information (Drugs.com)
• Firmagon Consumer Information (Cerner Multum)
• Degarelix Consumer Information (Drugs.com)
• Degarelix Acetate Consumer Information (Wolters Kluwer)
• Degarelix Consumer Information (Cerner Multum)
• Degarelix Subcutaneous Advanced Consumer Information (Micromedex)

Alfaxan

Alfaxan may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Alfaxan

Alfaxalone

Alfaxalone is reported as an ingredient of Alfaxan in the following countries:

• Australia


• France


• New Zealand


• South Africa

International Drug Name Search

Nivaquine

Nivaquine may be available in the countries listed below.

UK matches:

• Nivaquine Syrup (sanofi-aventis) (SPC)

Ingredient matches for Nivaquine

Chloroquine

Chloroquine is reported as an ingredient of Nivaquine in the following countries:

• Argentina


• Tunisia

Chloroquine sulfate (a derivative of Chloroquine) is reported as an ingredient of Nivaquine in the following countries:

• Belgium


• France


• Ghana


• Kenya


• Luxembourg


• Nigeria


• South Africa


• Switzerland


• Uganda


• United Kingdom


• Zimbabwe

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Lovette

Lovette may be available in the countries listed below.

Ingredient matches for Lovette

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Lovette in the following countries:

• Netherlands

Levonorgestrel

Levonorgestrel is reported as an ingredient of Lovette in the following countries:

• Netherlands

International Drug Name Search

Delos

In the US, Delos (benzoyl peroxide topical) is a member of the drug class topical acne agents and is used to treat Acne and Perioral Dermatitis.

US matches:

• Delos Liquid


• Delos Lotion

Ingredient matches for Delos

Roxithromycin

Roxithromycin is reported as an ingredient of Delos in the following countries:

• Argentina

International Drug Name Search

Ketotifeno Terbol

Ketotifeno Terbol may be available in the countries listed below.

Ingredient matches for Ketotifeno Terbol

Ketotifen

Ketotifen is reported as an ingredient of Ketotifeno Terbol in the following countries:

• Peru

International Drug Name Search

Ovidrelle

Ovidrelle may be available in the countries listed below.

Ingredient matches for Ovidrelle

Chorionic Gonadotrophin

Chorionic Gonadotrophin alfa (a derivative of Chorionic Gonadotrophin) is reported as an ingredient of Ovidrelle in the following countries:

• Luxembourg

International Drug Name Search

Lyogen

Lyogen may be available in the countries listed below.

Ingredient matches for Lyogen

Fluphenazine

Fluphenazine dihydrochloride (a derivative of Fluphenazine) is reported as an ingredient of Lyogen in the following countries:

• Germany

International Drug Name Search

Tonophosphan

Tonophosphan may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Tonophosphan

Toldimfos

Toldimfos sodium salt (a derivative of Toldimfos) is reported as an ingredient of Tonophosphan in the following countries:

• France

International Drug Name Search

Procadax

Procadax may be available in the countries listed below.

Ingredient matches for Procadax

Ceftibuten

Ceftibuten dihydrate (a derivative of Ceftibuten) is reported as an ingredient of Procadax in the following countries:

• India

International Drug Name Search

Amoxistad plus

Amoxistad plus may be available in the countries listed below.

Ingredient matches for Amoxistad plus

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxistad plus in the following countries:

• Austria

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoxistad plus in the following countries:

• Austria

International Drug Name Search

Amidrone

Amidrone may be available in the countries listed below.

Ingredient matches for Amidrone

Amiodarone

Amiodarone is reported as an ingredient of Amidrone in the following countries:

• Oman

International Drug Name Search

Oxygen Liquid

Dosage Form: liquid
Oxygen Liquid LABEL

OXYGEN, REFRIGERATED LIQUID


USP


UN1073


LOT#:_______


CONTENTS:__________LITERS


OXYGEN 2


ALWAYS KEEP CONTAINER IN UPRIGHT POSITION


WARNING:   EXTREMELY COLD OXIDIZING LIQUID AND GAS UNDER

                         PRESSURE.

                         VIGOROUSLY ACCELERATES COMBUSTION.

                         COMBUSTIBLES IN CONTACT WITH LIQUID OXYGEN MAY

                         EXPLODE ON IGNITION OR IMPACT.

                         CAN CAUSE SEVERE FROSTBITE.


                         Keep oil, grease, and combustibles away.

                         Use only with equipment cleaned for oxygen service.

                         Store and use with adequate ventilation.

                         Do not get liquid in eyes, on skin or clothing.

                         For liquid withdrawal, wear face shield and gloves.

                         Avoid spills.  Do not walk on or roll equipment over spills.

                         Close valve after each use and when empty.

                         USe in accordance with the Material Safety Data Sheet (MSDS).


FIRST AID:   IN CASE OF FROSTBITE, obtain medical treatment immediately.


                                                          MEDICAL USE


WARNING!   For emergency use only when administered by properly trained

                         personnel for oxygen deficiency and resuscitation.  For all other

                         medical applications Rx Only.


                         Uninterrupted use of high concentrations of oxygen over a long

                         duration, without monitoring its effect on oxygen content of

                         arterial blood, may be harmful.  Use only with pressure reducing

                         equipment and apparatus designed for oxygen.  Do not attempt to

                         use on patients who have stopped breathing unless used in

                         conjunction with resuscitative equipment.


                         Produced by Air Liquefaction


                         DO NOT REMOVE THIS PRODUCT LABEL.


                                     WELDING AND THERAPY SERVICE INC.

                                                        5010 Crittenden Drive

                                                         Louisville, KY  40209

OXYGEN  oxygen  liquid

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 33344-006 Route of Administration RESPIRATORY (INHALATION) DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Oxygen (Oxygen) Oxygen 99 L  in 100 L

Inactive Ingredients Ingredient Name Strength No Inactive Ingredients Found

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 33344-006-01 30 L In 1 DEWAR None 2 33344-006-02 40 L In 1 DEWAR None 3 33344-006-03 154 L In 1 DEWAR None 4 33344-006-04 214 L In 1 DEWAR None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved medical gas		11/01/1971

Labeler - Welding & Therapy Service Inc. (056823511)

Registrant - Welding & Therapy Service Inc. (056823511)

Establishment
Name	Address	ID/FEI	Operations
Welding & Therapy Service Inc.		056823511	manufacture

Establishment
Name	Address	ID/FEI	Operations
Welding & Therapy Service Inc.		082284167	manufacture

Establishment
Name	Address	ID/FEI	Operations
Weld-Rite Supply Corporation		010505035	manufacture

Revised: 08/2010Welding & Therapy Service Inc.

More Oxygen Liquid resources

• Oxygen Liquid Drug Interactions
• Oxygen Liquid Support Group
• 0 Reviews · Be the first to review/rate this drug

Flucon-ac

Flucon-ac may be available in the countries listed below.

Ingredient matches for Flucon-ac

Fluconazole

Fluconazole is reported as an ingredient of Flucon-ac in the following countries:

• Germany

International Drug Name Search

Cincor

Cincor may be available in the countries listed below.

Ingredient matches for Cincor

Bisoprolol

Bisoprolol is reported as an ingredient of Cincor in the following countries:

• Tunisia

International Drug Name Search

LisiHexal comp

LisiHexal comp may be available in the countries listed below.

Ingredient matches for LisiHexal comp

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of LisiHexal comp in the following countries:

• Germany

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of LisiHexal comp in the following countries:

• Germany

International Drug Name Search

Acétylcystéine Biogaran

Acétylcystéine Biogaran may be available in the countries listed below.

Ingredient matches for Acétylcystéine Biogaran

Acetylcysteine

Acetylcysteine is reported as an ingredient of Acétylcystéine Biogaran in the following countries:

• France

International Drug Name Search

Pyrexin

Pyrexin may be available in the countries listed below.

Ingredient matches for Pyrexin

Paracetamol

Paracetamol is reported as an ingredient of Pyrexin in the following countries:

• Indonesia

International Drug Name Search

Anusol-HC

In the US, Anusol-HC (hydrocortisone topical) is a member of the drug class topical steroids and is used to treat Anal Itching, Hemorrhoids and Proctitis.

US matches:

• Anusol-HC Cream


• Anusol-HC Suppositories


• Anusol-HC cream, ointment, suppository

Ingredient matches for Anusol-HC

Hydrocortisone

Hydrocortisone is reported as an ingredient of Anusol-HC in the following countries:

• United States

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Anusol-HC in the following countries:

• Argentina


• Canada


• Ireland

Zinc Sulfate

Zinc Sulfate is reported as an ingredient of Anusol-HC in the following countries:

• Canada

International Drug Name Search

Terbistad

Terbistad may be available in the countries listed below.

Ingredient matches for Terbistad

Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbistad in the following countries:

• Czech Republic


• Poland


• Slovakia

International Drug Name Search

Glomox

Glomox may be available in the countries listed below.

Ingredient matches for Glomox

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Glomox in the following countries:

• Bahrain


• Oman

International Drug Name Search

Cyproterone Acetate-Generics

Cyproterone Acetate-Generics may be available in the countries listed below.

Ingredient matches for Cyproterone Acetate-Generics

Cyproterone

Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Cyproterone Acetate-Generics in the following countries:

• Luxembourg

International Drug Name Search

olanzapine

oh-LAN-za-peen

Oral route(Tablet;Tablet, Disintegrating)

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death compared to placebo. Although the causes of death in clinical trials were varied, most of the deaths appeared to be either cardiovascular (eg, heart failure, sudden death) or infectious (eg, pneumonia) in nature. Observational studies suggest that antipsychotic drugs may increase mortality. It is unclear from these studies to what extent the mortality findings may be attributed to the antipsychotic drug as opposed to patient characteristics. Olanzapine is not approved for the treatment of patients with dementia-related psychosis .

Commonly used brand name(s)

In the U.S.

• Zyprexa


• Zyprexa Zydis

Available Dosage Forms:

• Tablet


• Tablet, Disintegrating

Therapeutic Class: Antipsychotic

Chemical Class: Thienobenzodiazepine

Uses For olanzapine

Olanzapine is used to treat nervous, emotional, and mental conditions (e.g., schizophrenia). It may also be used alone or with other medicines (e.g., lithium or valproate) to treat bipolar disorder (manic-depressive illness) or mania that is part of bipolar disorder. olanzapine should not be used to treat behavioral problems in older adult patients who have dementia or Alzheimer's disease.

olanzapine is available only with your doctor's prescription.

Before Using olanzapine

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For olanzapine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to olanzapine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of olanzapine in teenagers 13 to 17 years of age. However, safety and efficacy of olanzapine in children younger than 13 years of age have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of olanzapine in the elderly. However, elderly patients are more likely to have dementia or age-related liver, kidney, or heart problems, which may require caution or an adjustment in the dose for patients receiving olanzapine.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking olanzapine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using olanzapine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Levomethadyl


• Metoclopramide

Using olanzapine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Clomipramine


• Hydromorphone


• Lithium


• Milnacipran


• Mirtazapine


• Tetrabenazine


• Tramadol

Using olanzapine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Betel Nut


• Carbamazepine


• Ciprofloxacin


• Fluvoxamine


• Haloperidol


• Valproic Acid

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Other Medical Problems

The presence of other medical problems may affect the use of olanzapine. Make sure you tell your doctor if you have any other medical problems, especially:

• Blood vessel disease or circulation problems or


• Dehydration or


• Heart attack or stroke, history of or


• Heart disease or


• Heart failure or


• Heart rhythm problems or


• Hypotension (low blood pressure) or


• Hypovolemia (low blood volume)—May cause side effects to become worse.

• Breast cancer, prolactin-dependent or


• Glaucoma, narrow-angle or


• Hyperlipidemia (high cholesterol or fat in the blood) or


• Hyperprolactinemia (high prolactin in the blood) or


• Liver disease or


• Paralytic ileus (severe intestinal problem), history of or


• Prostatic hypertrophy (enlarged prostate) or


• Seizures, history of—Use with caution. olanzapine may make these conditions worse.

• Diabetes or


• Hyperglycemia (high blood sugar)—olanzapine may raise your blood sugar levels.

• Phenylketonuria (PKU, a genetic disease of metabolism)—The orally disintegrating tablet (Zyprexa® Zydis®) contains phenylalanine, which can make this condition worse.

Proper Use of olanzapine

Take olanzapine exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.

olanzapine should come with a medication guide. Read and follow these instructions carefully. Ask your doctor or pharmacist if you have any questions. Ask your pharmacist for the medication guide if you do not have one.

If you are using the orally disintegrating tablet (Zyprexa® Zydis®), make sure your hands are dry before you handle the tablet. Do not open the blister pack that contains the tablet until you are ready to take it. Remove the tablet from the blister pack by peeling back the foil, then taking the tablet out. Do not push the tablet through the foil. Place the tablet in your mouth. It should melt quickly. After the tablet has melted, swallow or take a sip of water.

You may take olanzapine with or without food.

Tell your doctor if you smoke tobacco. You might need a different amount of olanzapine if you smoke.

Dosing

The dose of olanzapine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of olanzapine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For oral dosage form (orally disintegrating tablets, regular tablets):
  
  • For treatment of schizophrenia:
    
    • Adults—At first, 5 to 10 milligrams (mg) once a day. Your doctor may adjust your dose if needed. However, the dose is usually not more than 20 mg per day.
    
    
    • Teenagers and children 13 to 17 years of age—At first, 2.5 or 5 milligrams (mg) once a day. Your doctor may adjust your dose if needed. However, the dose is usually not more than 20 mg per day.
    
    
    • Children younger than 13 years of age—Use and dose must be determined by your doctor.
    
    
  
  
  • For treatment of bipolar disorder:
    
    • Adults—At first, 5 to 15 milligrams (mg) once a day. Your doctor may adjust your dose if needed. However, the dose is usually not more than 20 mg per day.
    
    
    • Teenagers and children 13 to 17 years of age—At first, 2.5 or 5 milligrams (mg) once a day. Your doctor may adjust your dose if needed. However, the dose is usually not more than 20 mg per day.
    
    
    • Children younger than 13 years of age—Use and dose must be determined by your doctor.
    
    
  
  
  • For treatment of mania with bipolar disorder:
    
    • Adults—At first, 10 to 15 milligrams (mg) once a day. Your doctor may adjust your dose if needed. However, the dose is usually not more than 20 mg per day.
    
    
    • Teenagers and children 13 to 17 years of age—At first, 2.5 or 5 milligrams (mg) once a day. Your doctor may adjust your dose if needed. However, the dose is usually not more than 20 mg per day.
    
    
    • Children younger than 13 years of age—Use and dose must be determined by your doctor.
    
    
  
  

Missed Dose

If you miss a dose of olanzapine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Precautions While Using olanzapine

It is very important that your doctor check your or your child's progress at regular visits to make sure olanzapine is working properly. Blood tests may be needed to check for unwanted effects.

For some patients, olanzapine can increase thoughts of suicide. Tell your doctor right away if you or your child start to feel more depressed and have thoughts about hurting yourself. Report any unusual thoughts or behaviors that trouble you, especially if they are new or are getting worse quickly. Make sure the doctor knows if you or your child have trouble sleeping, get upset easily, have a big increase in energy, or start to act reckless. Also tell the doctor if you have sudden or strong feelings, such as feeling nervous, angry, restless, violent, or scared. Let the doctor know if you or anyone in your family has bipolar disorder (manic-depressive illness) or has tried to commit suicide.

olanzapine may increase the amount of sugar in your blood. Check with your doctor right away if you have increased thirst or increased urination. If you or your child have diabetes, you may notice a change in the results of your urine or blood sugar tests. If you have any questions, check with your doctor.

olanzapine may increase your cholesterol and fats in the blood. If this condition occurs, your doctor may give you or your child some medicines that can lower the amount of cholesterol and fats in the blood.

olanzapine may increase your weight. Your doctor may need to check your or your child's weight on a regular basis while you are using olanzapine.

Stop taking olanzapine and check with your doctor right away if you or your child have any of the following symptoms while using olanzapine: convulsions (seizures), difficulty with breathing, a fast heartbeat, a high fever, high or low blood pressure, increased sweating, loss of bladder control, severe muscle stiffness, unusually pale skin, or tiredness. These could be symptoms of a serious condition called neuroleptic malignant syndrome (NMS).

olanzapine may cause tardive dyskinesia (a movement disorder). Check with your doctor right away if you or your child have any of the following symptoms while taking olanzapine: lip smacking or puckering, puffing of the cheeks, rapid or worm-like movements of the tongue, uncontrolled chewing movements, or uncontrolled movements of the arms and legs.

Dizziness, lightheadedness, or fainting may occur, especially when you get up from a lying or sitting position. Getting up slowly may help. If this problem continues or gets worse, check with your doctor.

olanzapine can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. If you can, avoid people with infections. Check with your doctor immediately if you or your child think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.

Olanzapine may cause drowsiness, trouble with thinking, trouble with controlling body movements, or trouble with your vision. Make sure you know how you react to olanzapine before you drive, use machines, or do other jobs that require you to be alert, well-coordinated, or able to think or see well.

olanzapine may add to the effects of alcohol and other central nervous system (CNS) depressants (medicines that make you drowsy or less alert). Some examples of CNS depressants are antihistamines or medicines for allergies or colds; sedatives, tranquilizers, or sleeping medicines; prescription pain medicines or narcotics; medicines for seizures or barbiturates; muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any CNS depressants while you are taking olanzapine.

olanzapine may make it more difficult for your body to cool down. It might reduce how much you sweat. Your body could get too hot if you do not sweat enough. If your body gets too hot, you might feel dizzy, weak, tired, or confused. You might vomit or have an upset stomach. Do not get too hot while you are exercising. Avoid places that are very hot. Call your doctor if you are too hot and can not cool down.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines) and herbal or vitamin supplements.

olanzapine Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

More common

• Bloating or swelling of the face, arms, hands, lower legs, or feet


• blurred vision


• change in vision


• change in walking and balance


• clumsiness or unsteadiness


• difficulty with speaking


• difficulty with swallowing


• drooling


• impaired vision


• inability to sit still


• loss of balance control


• mask-like face


• muscle trembling, jerking, or stiffness


• need to keep moving


• rapid weight gain


• restlessness


• shakiness in the legs, arms, hands, or feet


• shuffling walk


• slowed movements


• slurred speech


• stiffness of the arms and legs


• tic-like (jerky) movements of the head, face, mouth, and neck


• tingling of the hands or feet


• trembling or shaking of the fingers, hands, or feet


• twisting movements of the body


• uncontrolled movements, especially of the face, neck, and back


• unusual weight gain or loss

Less common

• Bladder pain


• bloody or cloudy urine


• bruising


• burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings


• chest pain


• difficult or labored breathing


• difficult, burning, or painful urination


• dizziness


• excessive muscle tone


• frequent urge to urinate


• headache


• inability to move the eyes


• increased blinking or spasms of the eyelid


• itching of the vagina or genital area


• lack of coordination


• large, flat, blue, or purplish patches in the skin


• loss of bladder control


• loss of memory


• lower back or side pain


• muscle tension or tightness


• nervousness


• pain during sexual intercourse


• pounding in the ears


• problems with memory


• rhythmic movement of the muscles


• shortness of breath


• slow, fast, pounding, or irregular heartbeat or pulse


• speaking is less clear than usual


• sticking out the tongue


• thick, white vaginal discharge with no odor or with a mild odor


• tightness in the chest


• trouble with breathing, speaking, or swallowing


• twitching


• uncontrolled twisting movements of the neck, trunk, arms, or legs


• unusual or incomplete body or facial movements


• weakness of the arms and legs


• wheezing

Get emergency help immediately if any of the following symptoms of overdose occur:

Symptoms of overdose

• Anxiety


• attacking, assaulting, or using force


• change in consciousness


• change in patterns and rhythms of speech


• confusion as to time, place, or person


• convulsions (seizures)


• dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly


• drowsiness


• dry mouth


• fainting


• hallucinations


• heart stops beating


• high fever


• high or low blood pressure


• holding false beliefs that cannot be changed by fact


• increased sweating


• irregular, fast or slow, or shallow breathing


• irritability


• lightheadedness


• loss of consciousness


• mood or mental changes


• no breathing


• no pulse or blood pressure


• pale or blue lips, fingernails, or skin


• rapid breathing


• relaxed and calm


• severe muscle stiffness


• shaking or trembling


• sleepiness


• trouble with sleeping


• unconscious


• unusual excitement, nervousness, or restlessness


• unusual tiredness or weakness


• unusually pale skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Acid or sour stomach


• back pain


• belching


• change in personality


• difficulty having a bowel movement (stool)


• discouragement


• feeling sad or empty


• fever


• heartburn


• increased appetite


• increased cough


• indigestion


• lack of appetite


• lack or loss of strength


• loss of interest or pleasure


• runny nose


• sleeplessness


• sneezing


• stomach discomfort, upset, or pain


• stuffy nose


• thirst


• trouble with concentrating


• unable to sleep


• watering of the mouth


• weight gain

Less common

• Blemishes on the skin


• body aches or pain


• chills


• cold sweats


• congestion


• cough


• dry skin


• dryness or soreness of the throat


• false or unusual sense of well-being


• joint pain


• heavy menstrual bleeding (periods)


• hoarseness


• lack of feeling or emotion


• leg cramps


• pain in the arms or legs


• pimples


• sweating


• tender, swollen glands in the neck


• uncaring feelings


• voice change


• vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: olanzapine side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More olanzapine resources

• Olanzapine Side Effects (in more detail)
• Olanzapine Use in Pregnancy & Breastfeeding
• Drug Images
• Olanzapine Drug Interactions
• Olanzapine Support Group
• 90 Reviews for Olanzapine - Add your own review/rating

• Olanzapine Professional Patient Advice (Wolters Kluwer)


• Olanzapine MedFacts Consumer Leaflet (Wolters Kluwer)


• Olanzapine Monograph (AHFS DI)


• Zyprexa Prescribing Information (FDA)


• Zyprexa MedFacts Consumer Leaflet (Wolters Kluwer)


• Zyprexa Consumer Overview


• Zyprexa Relprevv Prescribing Information (FDA)


• Zyprexa Relprevv MedFacts Consumer Leaflet (Wolters Kluwer)


• Zyprexa Relprevv Consumer Overview


• Zyprexa Zydis Orally Disintegrating Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

Compare olanzapine with other medications

• Agitation
• Anorexia
• Asperger Syndrome
• Bipolar Disorder
• Body Dysmorphic Disorder
• Borderline Personality Disorder
• Depression
• Insomnia
• Obsessive Compulsive Disorder
• Paranoid Disorder
• Schizoaffective Disorder
• Schizophrenia
• Tourette's Syndrome